Počet záznamov: 1
Can we influence manifestation of metabolic syndrome by using antipsychotic drugs in patients with schizophrenia?
SYS 0062530 LBL 00000naa^^22^^^^^^^^450 005 20110503170846.8 100 $a 20110503a2007 m y0sloy0103 ba 101 0-
$a eng 102 $a SK 200 1-
$a Can we influence manifestation of metabolic syndrome by using antipsychotic drugs in patients with schizophrenia? $f Vachulova A. ... [et al.] 215 $c ilustr., tab. 305 $a European heart journal, vol. 28, suppl. 1 (2008), s. 347 463 -1
$1 001 sllk_un_cat*0012343 $1 011 $a 1210-0048 $1 200 1 $a Kardiológia $d Cardiology $i Program, súhrny a zborník abstraktov XII. kongres Slovenskej kardiologickej spoločnosti : Bratislava, 4. -6. október 2007 $z eng $v Vol. 16, suppl. 1 (2007), s. 56S $1 210 $a Bratislava $c SymeKard $1 215 $a s. 5S-62S 701 -1
$3 sllk_un_auth*p0040887 $a Vachulová $b Anna $p 2. interná klinika LFUK a FNsP, Bratislava $4 070 701 -1
$3 sllk_un_auth*0001325 $a Bukovinová $b Pavlína $p Klinika infektológie a geografickej medicíny LF UK, Bratislava $4 070 701 -1
$3 sllk_un_auth*p0041597 $a Penz $b Peter $p FNsP, Bratislava $4 070 701 -1
$3 sllk_un_auth*p0055150 $a Janoška $b Dalibor $p Psychiatrická nemocnica Ph. Pinela, Pezinok $4 070 701 -1
$3 sllk_un_auth*p0040888 $a Vohnout $b Branislav $p II. interná klinika LFUK a FNsP, Bratislava $4 070 712 12
$3 sllk_un_auth*0018073 $a European Society of Cardiology (ESC) $b Congress $e Vienna, Austria $f 2007 801 -0
$a SK $b BA006 $c 20110503 $g AACR2
Počet záznamov: 1